These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 15816541)
1. Comparative assessment of the functional p53 status in glioma cells. Kim EL; Yoshizato K; Kluwe L; Meissner H; Warnecke G; Zapf S; Westphal M; Deppert W; Giese A Anticancer Res; 2005; 25(1A):213-24. PubMed ID: 15816541 [TBL] [Abstract][Full Text] [Related]
2. p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 protein. Griewe GL; Dean RC; Zhang W; Young D; Sesterhenn IA; Shanmugam N; McLeod DG; Moul JW; Srivastava S Prostate Cancer Prostatic Dis; 2003; 6(4):281-5. PubMed ID: 14663467 [TBL] [Abstract][Full Text] [Related]
3. Mutation of the tumor suppressor gene p53 in human prostate and bladder cancers--investigation by temperature gradient gel electrophoresis (TGGE). Schlechte HH; Schnorr D; Löning T; Rudolph BD; Pohrt UM; Loening SA J Urol; 1997 Mar; 157(3):1049-53. PubMed ID: 9072541 [TBL] [Abstract][Full Text] [Related]
4. Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors. Vieyra D; Senger DL; Toyama T; Muzik H; Brasher PM; Johnston RN; Riabowol K; Forsyth PA Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5952-61. PubMed ID: 14676120 [TBL] [Abstract][Full Text] [Related]
5. Absence of p53 autoantibodies in sera from glioma patients. Rainov NG; Dobberstein KU; Fittkau M; Bahn H; Holzhausen HJ; Gantchev L; Burkert W Clin Cancer Res; 1995 Jul; 1(7):775-81. PubMed ID: 9816045 [TBL] [Abstract][Full Text] [Related]
6. Ethnicity delineates different genetic pathways in malignant glioma. Chen P; Aldape K; Wiencke JK; Kelsey KT; Miike R; Davis RL; Liu J; Kesler-Diaz A; Takahashi M; Wrensch M Cancer Res; 2001 May; 61(10):3949-54. PubMed ID: 11358811 [TBL] [Abstract][Full Text] [Related]
7. Analysis of p53 status in human cell lines using a functional assay in yeast: detection of new non-sense p53 mutation in codon 124. Smardová J; Pavlová S; Svitáková M; Grochová D; Ravcuková B Oncol Rep; 2005 Oct; 14(4):901-7. PubMed ID: 16142349 [TBL] [Abstract][Full Text] [Related]
8. Expression of p53 and prognosis in children with malignant gliomas. Pollack IF; Finkelstein SD; Woods J; Burnham J; Holmes EJ; Hamilton RL; Yates AJ; Boyett JM; Finlay JL; Sposto R; N Engl J Med; 2002 Feb; 346(6):420-7. PubMed ID: 11832530 [TBL] [Abstract][Full Text] [Related]
9. p53 gene and protein status: the role of p53 alterations in predicting outcome in patients with bladder cancer. George B; Datar RH; Wu L; Cai J; Patten N; Beil SJ; Groshen S; Stein J; Skinner D; Jones PA; Cote RJ J Clin Oncol; 2007 Dec; 25(34):5352-8. PubMed ID: 18048815 [TBL] [Abstract][Full Text] [Related]
10. The p53 gene and its role in human brain tumors. Bögler O; Huang HJ; Kleihues P; Cavenee WK Glia; 1995 Nov; 15(3):308-27. PubMed ID: 8586466 [TBL] [Abstract][Full Text] [Related]
11. Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters. Baumbusch LO; Myhre S; Langerød A; Bergamaschi A; Geisler SB; Lønning PE; Deppert W; Dornreiter I; Børresen-Dale AL Mol Cancer; 2006 Oct; 5():47. PubMed ID: 17054774 [TBL] [Abstract][Full Text] [Related]
12. Correlation of p53 immunoreactivity and sequencing in patients with glioma. Kyritsis AP; Xu R; Bondy ML; Levin VA; Bruner JM Mol Carcinog; 1996 Jan; 15(1):1-4. PubMed ID: 8561860 [TBL] [Abstract][Full Text] [Related]
13. p53 protein expression does not correlate with EBV status in childhood B non-Hodgkin lymphomas. Klumb CE; Hassan R; Zalcberg IR; Resende LM; Carriço MK; Maia RC Pediatr Blood Cancer; 2004 Aug; 43(2):115-9. PubMed ID: 15236276 [TBL] [Abstract][Full Text] [Related]
14. High prevalence of p53 exon 4 mutations in soft tissue sarcoma. Das P; Kotilingam D; Korchin B; Liu J; Yu D; Lazar AJ; Pollock RE; Lev D Cancer; 2007 Jun; 109(11):2323-33. PubMed ID: 17429838 [TBL] [Abstract][Full Text] [Related]
15. Distribution of p53 alterations in a case of gliomatosis cerebri. Mawrin C; Lins H; Kirches E; Schildhaus HU; Scherlach C; Kanakis D; Dietzmann K Hum Pathol; 2003 Jan; 34(1):102-6. PubMed ID: 12605375 [TBL] [Abstract][Full Text] [Related]
16. Analysis of p53 gene mutations in human glioma cell lines. Koga H; Zhang S; Washiyama K; Ichikawa T; Onda K; Kumanishi T Noshuyo Byori; 1996 Apr; 13(1):1-10. PubMed ID: 8916120 [TBL] [Abstract][Full Text] [Related]
17. Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines. Wasielewski M; Elstrodt F; Klijn JG; Berns EM; Schutte M Breast Cancer Res Treat; 2006 Sep; 99(1):97-101. PubMed ID: 16541312 [TBL] [Abstract][Full Text] [Related]
18. p53 mutation and protein alteration in 50 gliomas. Retrospective study by DNA-sequencing techniques and immunohistochemistry. von Eckardstein K; Gries H; Bolik E; Cervós-Navarro J; Tschairkin IN; Patt S Histol Histopathol; 1997 Jul; 12(3):611-6. PubMed ID: 9225141 [TBL] [Abstract][Full Text] [Related]
19. Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines. Liu Y; Bodmer WF Proc Natl Acad Sci U S A; 2006 Jan; 103(4):976-81. PubMed ID: 16418264 [TBL] [Abstract][Full Text] [Related]
20. Accumulation of p53 protein as an indicator for p53 gene mutation in breast cancer. Occurrence of false-positives and false-negatives. Lohmann D; Ruhri C; Schmitt M; Graeff H; Höfler H Diagn Mol Pathol; 1993 Mar; 2(1):36-41. PubMed ID: 8287224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]